Phreesia had its Relative Strength (RS) Rating upgraded from 64 to 81 Thursday.
Looking For The Best Stocks To Buy And Watch? Start Here
This proprietary rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
History reveals that the best stocks typically have an RS Rating of above 80 in the early stages of their moves.
Phreesia is trying to complete a consolidation with a 30.53 entry. See if it can clear the breakout price in volume at least 40% higher than normal.
The company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 15%.
The company earns the No. 8 rank among its peers in the Computer Software-Medical industry group. Doximity, Waystar Holding and Certara are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
